Breaking News Instant updates and real-time market news.

EA

Electronic Arts

$95.49

11.4 (13.56%)

14:51
02/08/19
02/08
14:51
02/08/19
14:51

Cowen says 'far too early' to project how Apex Legends may impact EA's FY20

While Apex Legends is off to "an undeniably strong start," Cowen analyst Doug Creutz said it is "far (very far) too early" to project how the game may impact FY20 results at Electronic Arts. The game could be "a flash in the pan, or a lasting phenomenon," and there is "simply no way to know right now" which it will be, Creutz tells investors. He maintains a Market Perform rating and $71 price target on Electronic Arts shares.

  • 14

    Feb

  • 25

    Feb

EA Electronic Arts
$95.49

11.4 (13.56%)

02/06/19
RHCO
02/06/19
NO CHANGE
Target $90
RHCO
Buy
Electronic Arts price target lowered to $90 from $105 at SunTrust
SunTrust analyst Matthew Thornton lowered his price target on Electronic Arts to $90 after its disappointing Q3 results, also lowering his FY19, FY20, and FY21 EPS view to $3.88, $4.12, and $4.66 from $4.65, $5.13, and $5.58 respectively. The analyst keeps his Buy rating however, stating that the outlook for Electronic Arts has been "de-risked" as the company heads into more favorable seasonality. Thornton adds that his forward view of EA's console and PC franchises are unchanged, even though his outlook for mobile gaming which is about 12% of total sales is "incrementally negative".
02/07/19
BARD
02/07/19
NO CHANGE
Target $90
BARD
Outperform
Electronic Arts's 'Apex Legends' engagement looks impressive, says Baird
Baird analyst Colin Sebastian kept his Outperform rating and $90 price target on Electronic Arts, saying its free-to-play Apex Legends game has now reached 10M active players with over 1M peak concurrent players. The analyst says the early engagement appears impressive and player feedback has been mostly positive, likely leading to upside for the stock "if user growth and monetization trends can maintain the game's early momentum."
02/08/19
BMOC
02/08/19
NO CHANGE
Target $96
BMOC
Outperform
Electronic Arts price target lowered to $96 from $110 at BMO Capital
BMO Capital analyst Gerrick Johnson lowered his price target on Electronic Arts to $96 after its disappointing quarter highlighted by "underperforming" Battlefield V and mobile gaming. The analyst keeps his Outperform rating however, citing "improved" conversation around sports games and the possibility of immediate success of Apex Legends outweighing the "lackluster Q4" outlook over the long term.
02/08/19
BUCK
02/08/19
NO CHANGE
Target $90
BUCK
Buy
Electronic Arts 'smashes' early expectations with Apex Legends, says Buckingham
Buckingham analyst Matthew Harrigan noted that Apex Legends, Electronic Arts' free-to-play battle royale game, has reached 10M players in just three days, which he said is faster than Fortnite, which required two weeks to get to that level. The reaction in EA shares this morning to the news "exemplifies how hit driven video gaming stocks remain," said Harrigan, who keeps a Buy rating and $90 price target on Electronic Arts shares.

TODAY'S FREE FLY STORIES

PS

Pluralsight

$30.66

-0.71 (-2.26%)

07:20
07/17/19
07/17
07:20
07/17/19
07:20
Initiation
Pluralsight initiated  »

KeyBanc bullish on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jul

CSX

CSX

$79.57

1.05 (1.34%)

07:20
07/17/19
07/17
07:20
07/17/19
07:20
Downgrade
CSX rating change  »

CSX downgraded to Equal…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Aug

  • 13

    Nov

07:20
07/17/19
07/17
07:20
07/17/19
07:20
General news
FX Update: EUR-USD edged out a fresh eight-day low »

FX Update: EUR-USD edged…

CTRP

Ctrip

$36.87

-0.48 (-1.29%)

07:19
07/17/19
07/17
07:19
07/17/19
07:19
Hot Stocks
Ctrip to upgrade Global SOS Emergency Response platform with UNDP »

Ctrip.com International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UAL

United Continental

$94.00

2.7 (2.96%)

07:19
07/17/19
07/17
07:19
07/17/19
07:19
Recommendations
United Continental analyst commentary  »

United Continental target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

NVS

Novartis

$89.12

-0.2 (-0.22%)

07:18
07/17/19
07/17
07:18
07/17/19
07:18
Conference/Events
Novartis management to meet with Wolfe Research »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 22

    Jul

  • 23

    Jul

  • 25

    Sep

SCHW

Charles Schwab

$41.62

1.34 (3.33%)

07:17
07/17/19
07/17
07:17
07/17/19
07:17
Recommendations
Charles Schwab analyst commentary  »

Charles Schwab net…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

  • 27

    Oct

IAC

IAC

$231.54

-2.55 (-1.09%)

07:17
07/17/19
07/17
07:17
07/17/19
07:17
Hot Stocks
IAC to invest $250M in Turo car sharing marketplace »

IAC has agreed to invest…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TWOU

2U

$38.60

-0.34 (-0.87%)

07:17
07/17/19
07/17
07:17
07/17/19
07:17
Initiation
2U initiated  »

KeyBanc bullish on 2U,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALEC

Alector

$19.06

0.06 (0.32%)

07:15
07/17/19
07/17
07:15
07/17/19
07:15
Conference/Events
Alector management to meet with Morgan Stanley »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jul

  • 09

    Sep

VEGPF

Vectura Group

$0.00

(0.00%)

07:14
07/17/19
07/17
07:14
07/17/19
07:14
Hot Stocks
Vectura Group continues to seek partner for VR647 Phase III development »

The company said,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NUS

Nu Skin

$45.50

1.44 (3.27%)

07:13
07/17/19
07/17
07:13
07/17/19
07:13
Downgrade
Nu Skin rating change  »

Jefferies downgrades Nu…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Aug

VEGPF

Vectura Group

$0.00

(0.00%)

07:13
07/17/19
07/17
07:13
07/17/19
07:13
Hot Stocks
Vectura Group board approves capital return of approx. GBP50M »

The company said,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOG

Alphabet

$1,152.97

2.58 (0.22%)

, GOOGL

Alphabet Class A

$1,152.86

2.4 (0.21%)

07:13
07/17/19
07/17
07:13
07/17/19
07:13
Recommendations
Alphabet, Alphabet Class A, Facebook, Twitter analyst commentary  »

KeyBanc expects…

GOOG

Alphabet

$1,152.97

2.58 (0.22%)

GOOGL

Alphabet Class A

$1,152.86

2.4 (0.21%)

FB

Facebook

$203.87

-0.06 (-0.03%)

TWTR

Twitter

$38.00

-0.68 (-1.76%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

  • 17

    Jul

  • 24

    Jul

  • 25

    Jul

  • 25

    Jul

  • 26

    Jul

  • 30

    Jul

  • 08

    Aug

  • 27

    Oct

CSII

Cardiovascular Systems

$44.00

-1.9 (-4.14%)

07:12
07/17/19
07/17
07:12
07/17/19
07:12
Conference/Events
Cardiovascular Systems management to meet with Lake Street »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 06

    Aug

  • 09

    Sep

  • 12

    Sep

VEGPF

Vectura Group

$0.00

(0.00%)

07:11
07/17/19
07/17
07:11
07/17/19
07:11
Hot Stocks
Vectura Group confirms R&D investment priorities »

The company said,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WFC

Wells Fargo

$45.30

-1.4 (-3.00%)

07:10
07/17/19
07/17
07:10
07/17/19
07:10
Recommendations
Wells Fargo analyst commentary  »

Wells Fargo price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Oct

VMW

VMware

$172.25

0.03 (0.02%)

07:09
07/17/19
07/17
07:09
07/17/19
07:09
Recommendations
VMware analyst commentary  »

VMware estimates likely…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

SMMT

Summit Therapeutics

$1.35

-0.06 (-4.26%)

07:09
07/17/19
07/17
07:09
07/17/19
07:09
Hot Stocks
Summit presents preclinical data on SMT-571 at STI & HIV World Congress »

Summit Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GHSI

Guardion Health Sciences

$0.97

-0.03 (-3.02%)

07:07
07/17/19
07/17
07:07
07/17/19
07:07
Hot Stocks
Guardion Health Sciences receives patent for MapcatSF in Hong Kong »

Guardion Health Sciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DPZ

Domino's Pizza

$246.55

-23.42 (-8.68%)

07:06
07/17/19
07/17
07:06
07/17/19
07:06
Recommendations
Domino's Pizza analyst commentary  »

Domino's Pizza…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

PSTI

Pluristem

$0.57

0.0319 (5.87%)

07:05
07/17/19
07/17
07:05
07/17/19
07:05
Hot Stocks
Pluristem, U.S. DoD to announce data from studies testing PLX-R18 »

Pluristem Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GS

Goldman Sachs

$215.57

4.02 (1.90%)

, MS

Morgan Stanley

$44.41

-0.01 (-0.02%)

07:05
07/17/19
07/17
07:05
07/17/19
07:05
Recommendations
Goldman Sachs, Morgan Stanley analyst commentary  »

Goldman Sachs price…

GS

Goldman Sachs

$215.57

4.02 (1.90%)

MS

Morgan Stanley

$44.41

-0.01 (-0.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 15

    Oct

ACIU

AC Immune

$5.62

0.1 (1.81%)

, LLY

Eli Lilly

$108.81

0.36 (0.33%)

07:04
07/17/19
07/17
07:04
07/17/19
07:04
Hot Stocks
AC Immune initiates Phase 1 study of ACI-3024 »

AC Immune SA (ACIU)…

ACIU

AC Immune

$5.62

0.1 (1.81%)

LLY

Eli Lilly

$108.81

0.36 (0.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jul

  • 09

    Sep

  • 16

    Sep

  • 02

    Oct

ANIX

Anixa Biosciences

$4.14

-0.01 (-0.24%)

07:03
07/17/19
07/17
07:03
07/17/19
07:03
Hot Stocks
Anixa Biosciences partnering with Cleveland Clinic for breast cancer vaccine »

Anixa Biosciences has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.